Abstract
Bone marrow mesenchymal stem cells (MSC) play essential roles in supporting hematopoiesis, and dysfunctions of these cells are associated with leukemia. However, whether restoration of the impaired bone marrow (BM) microenvironment can inhibit leukemia remains unknown. Using an established model of mimicking chronic MPN/MDS diseases, we uncovered a deteriorating bone marrow microenvironment associated with the disease development. Intra-bone-marrow instead of systemic transfusion of healthy MSC restored the local bone marrow microenvironment, systemically improved thrombopoiesis and reduced tumor burden, and prolonged survivals in leukemia setting. Mechanistically, the transient donor MSC immediately reprogrammed the leukemia macrophages to fulfill tissue repairing function. Further, transfusion of in vitro MSC-reprogrammed macrophages largely recapitulated the microenvironment restoration and therapeutic effects of MSC. Our study reveals the pivotal role of resident macrophages for MSC-mediated microenvironment restoration and therapeutic effects in a chronic leukemia setting, which provides insights into translational application of MSC in MDS/MPN leukemia patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
